Overview
Efficacy and Safety of Aripiprazole in Patients With Schizophrenia or Bipolar Disorder
Status:
Completed
Completed
Trial end date:
2009-12-01
2009-12-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This is a multicenter,open-label,prospective study of Aripiprazole use in patients with schizophrenia and bipolar disorder.Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Korea Otsuka Pharmaceutical Co., Ltd.Treatments:
Aripiprazole
Criteria
Inclusion Criteria:- Patient with a schizophrenia or schizoaffective disorder or bipolar disorder according
to DSM-IV criteria
- Age: more than 18 years of age
Exclusion Criteria:
- Unqualified patients judged by study investigator(s)